This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Lymperi S, Ersek A, Ferraro F, Dazzi F, Horwood NJ . Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. Blood 2011; 117: 1540–1549.
Ghobrial IM, Dispenzieri A, Bundy KL, Gastineasu DA, Rajkumar SV, Therneau TM et al. Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma. Bone Marrow Transplant 2003; 32: 587–592.
Breitkreutz I, Lokhorst HM, Raab MS, Holt Bv, Cremer FW, Herrmann D et al. Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield. Leukemia 2007; 21: 1294–1299.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Oksman, M., Itälä-Remes, M., Kauppila, M. et al. Bisphosphonates do not delay engraftment after autologous SCT in patients with newly diagnosed myeloma. Bone Marrow Transplant 50, 157 (2015). https://doi.org/10.1038/bmt.2014.225
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2014.225